Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 12
Submit an article Journal homepage
58
Views
0
CrossRef citations to date
0
Altmetric
Letter

Do matrix metalloproteinase-1 and glucose-6-phosphate dehydrogenase gene polymorphisms interact in promoting lymphoma development?

Maria G. EnnasDepartment of Biomedical Sciences
,
Mariagrazia ZuccaDepartment of Biomedical Sciences
,
Giannina SattaOccupational Health Section, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Monserrato, Italy
,
Tinucia NonneOccupational Health Section, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Monserrato, Italy
,
Emanuele AngelucciDepartment of Hematology, Oncology Hospital “A. Businco”, Cagliari, Italy
,
Attilio GabbasOccupational Health Section, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Monserrato, Italy
,
Marco RaisOccupational Health Section, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Monserrato, Italy
,
Aldo ScarpaDepartment of Pathology, University of Verona, Verona, Italy
&
Pierluigi CoccoOccupational Health Section, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Monserrato, ItalyCorrespondence[email protected]
 show all
Pages 2734-2735 | Received 06 Nov 2012, Accepted 09 Mar 2013, Published online: 17 Apr 2013

References

  • Luzzatto L, Mehta A, Vulliamy T. Glucose 6-phosphate dehydrogenase deficiency. In: Scriver CR, Beaudet AL, Sly WS, editors. The metabolic basis of inherited diseases. 8th ed. New York: McGraw-Hill; 2001. pp 4517–4553.
  • Cocco P, Ennas MG, Melis MA, et al. Glucose-6-phosphate dehydrogenase polymorphism and lymphoma risk. Tumori 2007;93:121–123.
  • Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425–430.
  • Irani K, Xia Y, Zweier JL, et al. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 1997;275:1649–1652.
  • Lemons JM, Feng XJ, Bennett BD, et al. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol 2010;8:e1000514.
  • Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an ETS binding site and augments transcription. Cancer Res 1998;58: 5321–5325.
  • Tang C-H, Chen C-F, Chen W-M, et al. IL-6 increases MMP-13 expression and motility in human chondrosarcoma cells. J Biol Chem 2011;286:11056–11066.
  • Aschebrook-Kilfoy B, Zheng T, Foss F, et al. Polymorphisms in immune function genes and non-Hodgkin lymphoma survival. J Cancer Surviv 2012;6:102–114.
  • Kossakowska AE, Hinek A, Edwards DR, et al. Proteolytic activity of human non-Hodgkin's lymphomas. Am J Pathol 1998;152:565–576.
  • Kossakowska AE, Urbanski SJ, Janowska-Wieczorek A. Matrix metalloproteinases and their tissue inhibitors - expression, role and regulation in human malignant non-Hodgkin’s lymphomas. Leuk Lymphoma 2000;39:485–493.
  • Pennanen H, Kuittinen O, Turpeenniemi-Hujanen T. Plasma MMP-2-TIMP-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma. Eur J Haematol 2008;80:46–54.
  • Casabonne D, Reina O, Benavente Y, et al. Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP-9) and tumour protein 73 (TP73) interact with Epstein Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph. Haematologica 2011;96:323–327.
  • Przybylowska K, Kluczna A, Zadrozny M, et al. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat 2006;95:65–72.
  • Tasci AI, Tugcu V, Ozbek E, et al. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility. BJU Int 2008;101:503–507.
  • Xiao XY, Wang XD, Zang DY. MMP1-1607 1G/2G polymorphism and lung cancer risk: a meta-analysis. Tumour Biol 2012;33: 2385–2392.
  • Mesbah-Namin SA, Nemati A, Tiraihi T. Evaluation of DNA damage in leukocytes of G6PD-deficient Iranian newborns (Mediterranean variant) using comet assay. Mutat Res 2004;568:179–185.
  • Zhu Y, Spitz MR, Lei L, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001;61:7825–7829.
  • Kurdi-Haidar B, Mason PJ, Berrebi A, et al. Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet 1990;47:1013–1019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.